Clostridium perfringens enterotoxin, C-terminal fragment of CPE (C-CPE, a CLDN binding domain without cytotoxicity), and C-CPE fusion protein have been investigated for their therapeutic potential in cancer. The gene discussed is CPE; the disease is cancer.